Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cartwright PC et al. – Transdermal oxybutynin was a well tolerated and effective alternative to oral oxybutynin in treating neurogenic detrusor overactivity in children who previously tolerated oxybutynin.

Related Articles

Botulinum toxin type A for neurogenic detrusor overactivity due to spinal cord lesions in children: A retrospective study of seven cases
Journal of Pediatric Urology, 11/17/09    Relevance Score: 67%

Bladder Function After Total Urogenital Mobilization for Persistent Cloaca
The Journal of Urology, 10/30/09    Relevance Score: 66%

Second-line therapy of idiopathic detrusor overactivity
Der Urologe, 10/30/09    Relevance Score: 65%

Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity
International Urogynecology Journal, 11/17/09    Relevance Score: 64%

Is ultrasound estimation of bladder weight a useful tool in the assessment of patients with lower urinary tract symptoms
International Urogynecology Journal, 10/07/09    Relevance Score: 64%

Today in Pediatric Urology...keeping you current

Primary adrenal failure due to viral infection in an infant
European Journal of Pediatrics, 11/24/09

Prospective Study of Transcutaneous Parasacral Electrical Stimulation for Overactive Bladder in Children: Long-Term Results
The Journal of Urology, 11/24/09

Risk Factors for Nocturnal Enuresis in School-Age Children
The Journal of Urology, 11/24/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address